AltruBio Inc. Alternatives & Competitors
12 companies similar to AltruBio Inc. — Novel Therapeutics for Immunological Diseases
Companies similar to AltruBio Inc.
Tradewind BioScience
Innovative therapeutics for the most aggressive cancers
United States
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
January Therapeutics
Transformational Oncology
San Diego, United States
Apitope
Develops drugs for treatments of allergic diseases
Diepenbeek, Belgium
Track all AltruBio Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
MediMabBio
A biotechnology company that focuses on developing new therapeutic drugs targeting Oncolog...
Korea South
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
Marseille, France
Olatec Therapeutics
Leading the Development of Specific NLRP3 Antagonists, Mediator of Innate Inflammatory Re...
New York, United States
Palatin Technologies
We discover and develop novel therapeutics for patients living with inflammatory and autoi...
GEn1E Lifesciences Inc.
Clinical-stage, Phase 2 company accelerating novel Precision Therapies for I&I and Rare Di...
Palo Alto, United States
Kojin Therapeutics
Developing transformative medicines based on a groundbreaking approach to ferroptosis and...
Boston, United States
AnaptysBio
Transforming patient health by delivering innovative immunology therapeutics.
San Diego, United States
MetiMedi Co., Ltd.
MetiMedi is developing a first-in-class oral immunotherapeutic small molecule in Phase 2 f...
Korea South
About AltruBio Inc.
AltruBio Inc., founded in 2020, is carving out a niche in the Biotechnology and Health Care sectors with its mission to develop Novel Therapeutics for Immunological Diseases. This United States-based company is pioneering first-in-class immune-modulators targeting key areas in #immunology and #inflammation, driven by a...
Immunological Diseases, Immune-modulators, Biologic Treatments, Antibody Therapeutics, Cancer Treatment, Immune-related Inflammatory Diseases, Drug Development, Autoimmune Diseases, Pancreatic Cancer, Stomach Cancer, Colorectal Cancer, Ovarian Cancer, Lung Cancer, Solid Tumors, Novel Therapeutics
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches AltruBio Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at AltruBio Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
